Effect of core stability exercises on postpartum lumbopelvic pain: A randomized controlled trial

2019 ◽  
Vol 32 (2) ◽  
pp. 205-213
Author(s):  
Marwa Shafiek Mustafa Saleh ◽  
Afaf Mohamed Mahmoud Botla ◽  
Noran Ahmed Mohammed Elbehary
2016 ◽  
Vol 30 (10) ◽  
pp. 1024-1033 ◽  
Author(s):  
Rosa Cabanas-Valdés ◽  
Caritat Bagur-Calafat ◽  
Montserrat Girabent-Farrés ◽  
Fernanda Mª Caballero-Gómez ◽  
Montserrat Hernández-Valiño ◽  
...  

2019 ◽  
pp. 113-122
Author(s):  
Shahnaz Shahrjerdi ◽  
Fahimeh Mahmoudi ◽  
Rahman Sheikhhoseini ◽  
Samira Shahrjerdi

Author(s):  
Rosa Cabanas-Valdés ◽  
Lídia Boix-Sala ◽  
Montserrat Grau-Pellicer ◽  
Juan Antonio Guzmán-Bernal ◽  
Fernanda Maria Caballero-Gómez ◽  
...  

Background: Trunk impairment produces disorders of motor control, balance and gait. Core stability exercises (CSE) are a good strategy to improve local strength of trunk, balance and gait. Methods and analysis: This is a single-blind multicenter randomized controlled trial. Two parallel groups are compared, and both perform the same type of therapy. A control group (CG) (n = 110) performs conventional physiotherapy (CP) (1 h per session) focused on improving balance. An experimental group (EG) (n = 110) performs CSE (30 min) in addition to CP (30 min) (1 h/session in total). EG is divided in two subgroups, in which only half of patients (n = 55) perform CSE plus transcutaneous electrical nerve stimulation (TENS). Primary outcome measures are dynamic sitting, assessed by a Spanish version of Trunk Impairment Scale and stepping, assessed by Brunel Balance Assessment. Secondary outcomes are postural control, assessed by Postural Assessment Scale for Stroke patients; standing balance and risk of fall assessed by Berg Balance Scale; gait speed by BTS G-Walk (accelerometer); rate of falls, lower-limb spasticity by Modified Ashworth Scale; activities of daily living by Barthel Index; and quality of life by EQ-5D-5L. These are evaluated at baseline (T0), at three weeks (T1), at five weeks (end of the intervention) (T2), at 17 weeks (T3) and at 29 weeks (T4). Study duration per patient is 29 weeks (a five-week intervention, followed by a 24-week post-intervention).


Sign in / Sign up

Export Citation Format

Share Document